BIOSPECIFICS TECHNOLOGIES CORP 4

4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed Aug 30, 2016

Form 4

Period: 2016-08-30

DirectorPresident10% Owner

Transactions

Exercise/Conversion
Stock Option (Right to Buy)
2016-08-30−25,000→ 0 total
Exercise: $0.83From: 2006-09-06Exp: 2016-09-05→ Common Stock, $.001 par value (25,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2016-08-30−100,000→ 0 total
Exercise: $0.83Exp: 2016-09-05→ Common Stock, $.001 par value (100,000 underlying)
Exercise/Conversion
Common Stock, $.001 par value
2016-08-30$0.83/sh+25,000$20,750→ 212,549 total
Exercise/Conversion
Common Stock, $.001 par value
2016-08-30$0.83/sh+100,000$83,000→ 312,549 total

Footnotes (1)

[F1]On September 6, 2006, the reporting person was granted an option to purchase 100,000 shares of the Issuer's Common Stock. The option vested in two equal installments based on the reporting person's satisfaction of two distinct performance conditions. The first performance related condition was satisfied on October 24, 2007, resulting in the vesting of the option as to 50,000 shares. The second performance related condition was satisfied on April 2, 2010, resulting in the vesting of the option as to the remaining 50,000 shares.

Documents

1 file